For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education. Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease. It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications
Cleveland Clinic Diabetes Therapeutics, Technology and Surgery
Session 1: Type 1 Diabetes Corner
| Pump Update | Diana Isaacs, PharmD, BCPS, BC-ADM, CDE |
| Dual Hormone Pumps | Keren Zhou, MD |
| Do It Yourself Technology | Julia Blanchette, PhD, RN, CDCES |
| New Insulins | Robert S. Zimmerman, MD |
| Dawn of Glucagon | Vinni Makin, MD |
| Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes | Ali Aminian, MD |
| Are Sulfonyureas Safe? | Pratibha Rao, MD |
| Treatment of Type 2 Diabetes in Children | Jamie Wood, MD |
| New Treatment Options for Diabetes and the Kidney | Alexandra Mikhael, MD |
| GLP-1 Agonists: Oral VS. SubQ | Mario Skugor, MD |
| Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Early Manifestion of the Metabolic Syndrome | Adi Mehta, MD |
| Treatment of Hyperlipidemia in Type 2 Diabetes: Review of Current Guidelines | Dennis Bruemmer, MD, PhD |
Session 3: Fasting, Metformin and Management Issues
| Intermittent Fasting and Diabetes: What’s the Evidence? | Carolyn Garvey, RDN, LD, CDCES |
| Management of Hypoglycemia Post Gastric Bypass | Sangeeta Kashyap, MD |
| Role of Exercise in Management of Diabetes | Oscar Morey Vargas, MD |
| Understanding Metformin’s Actions Through the Interactions in the Gut | Leann Olansky, MD |
| T2D and CVD: Metformin Monotherapy | Kevin M. Pantalone, DO, ECNU, FACE |
| Diabetes Management in Patients with COVID-19 | Sana Hasan, DO |
| Endoscopic and Surgical Division of the Gastric Pylorus for Gastroparesis | Joshua Landreneau, MD |
